Skip to main content
Clinical Trials/NCT03999086
NCT03999086
Completed
Not Applicable

Thromboelastography-guided Fluid Management in Spinal Surgery: A Prospective Analysis

Mayo Clinic1 site in 1 country50 target enrollmentJanuary 12, 2018
ConditionsSpinal Fusion

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Spinal Fusion
Sponsor
Mayo Clinic
Enrollment
50
Locations
1
Primary Endpoint
Volume of transfused packed red blood cells
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The Researchers are trying to evaluate whether using a blood test called thromboelastogram (TEG) to manage patients undergoing multi-level spinal fusion surgery will reduce complications after surgery compared with the standard practices.

Detailed Description

Multi-level instrumented spinal fusions represent an important treatment modality for degenerative scoliosis and sagittal malalignment. These surgeries remain a significant physiologic burden with high blood loss and long operative times. Thromboelastography provides a quantitative measure for blood product transfusion surrounding procedures. We aim to utilize thromboelastography to guide transfusions for multi-level spinal instrumentation. This two-arm, randomized, non-blinded prospective analysis will clarify reduced transfusion requirements for TEG-arm compared to non-TEG arm. We will also evaluate postoperative outcomes at the 1 year time-point.

Registry
clinicaltrials.gov
Start Date
January 12, 2018
End Date
November 8, 2019
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jamal McClendon, Jr.

Principal Investigator

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

  • all patients undergoing elective multi-level spinal fusion for sagittal malalignment, multi-level spondylolisthesis, multi-level lumbar spinal stenosis, and adult degenerative scoliosis with ages between 18-89

Exclusion Criteria

  • patients with tumors, infection, or trauma

Outcomes

Primary Outcomes

Volume of transfused packed red blood cells

Time Frame: post operative approximately 1 day

Amount of transfused packed red blood cells measured in units of cc(mL)

Estimated Blood Loss

Time Frame: post operative approximately 1 day

Amount of blood loss measured in units of cc(mL)

Adverse Events

Time Frame: One year

Number of adverse events reported

Study Sites (1)

Loading locations...

Similar Trials